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Experimentally-induced hyperglycemia by prolonged glucose infusion allows investigation of the effects of sustained stimulation of the
pancreatic β-cell on insulin secretion and sensitivity. Hormonal responses to a meal following prolonged glucose infusions have not been
investigated. To determine if a 48-h glucose infusion alters hormonal responses to a test meal as well as food intake and hunger in normal weight
individuals, 16 subjects (8 men, 8 women, age 18–30 years, mean BMI=21.7±1.6 kg/m2) were infused for 48 h with either saline (50 ml/h) or
15% glucose (200 mg/m2/min). Subjects ingested a 600 kcal mixed nutrient meal 3 h after infusion termination. Blood samples were taken during
the 48 h and for 4 h following food ingestion. The 48-h glucose infusion elicited a metabolic profile of a glucose intolerant obese subjects, with
increased plasma glucose, insulin and leptin (all Pb0.01) and increased HOMA-IR (Pb0.001). During meal ingestion, early insulin secretion was
increased (Pb0.05) but post-prandial glucose (Pb0.01) and insulin (Pb0.01) excursions were lower following the glucose infusion. Post-prandial
plasma triglyceride concentrations were increased after glucose compared with saline. Food intake and hunger ratings were not different between
the two conditions. Plasma leptin levels were inversely correlated with hunger (Pb0.03) in both conditions and with food intake (Pb0.003) during
the glucose condition only. Thus, a 48-h glucose infusion does not impair post-prandial hormonal responses, alter food intake or hunger in
normal weight subjects. The glucose-induced increases in plasma leptin result in a stronger inverse relationship between plasma leptin and hunger
as well as food intake. These data are the first to demonstrate a relationship between leptin and hunger in normal weight, non-calorically restricted
human subjects.
© 2007 Elsevier Inc. All rights reserved.Keywords: Leptin; Insulin; Food intake; Insulin sensitivity; Triglycerides1. Introduction
Experimentally-induced hyperglycemia has been used as a
research tool to investigate the effects of chronically elevated
blood glucose levels on insulin secretion and sensitivity. While in
vitro studies suggest that sustained high levels of glucose result in
glucose toxicity and impaired insulin secretion [1], in vivo studies
involving 24-h to 48-h glucose infusions indicate that prolonged☆ Support: NIH DK58003-07 (K.T.), DK-19525, MO1-RR00042.
⁎ Corresponding author. Monell Chemical Senses Center, 3500 Market Street,
Philadelphia, PA 19104, United States. Tel.: +1 215 898 4999.
E-mail address: kteff@pobox.upenn.edu (K.L. Teff).
0031-9384/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.physbeh.2006.12.013glucose exposure can lead to hyperinsulinemia [2,3] and in some
cases, increased insulin sensitivity [4]. Discrepancies in results are
most likely due to the release of neurotransmitters and peptides
which may influence insulin secretion during the in vivo
experiments [5] but would not be present in the in vitro
experiments. Neural factors contributing to an increase in insulin
secretion after prolonged glucose exposure have been implicated
in both animal [6,7] and human studies [8] but the effect of the
elevated glucose levels on other hormones that could potentially
influence insulin sensitivity has not been investigated.
An additional factor contributing to differential responses
between the in vitro and in vivo experiments is the glucose
concentrations to which the β-cell is exposed as glucose levels
are typically lower in the in vivo studies. Glucose levels differ
734 K.L. Teff et al. / Physiology & Behavior 90 (2007) 733–743even more substantially between animal and human experi-
ments. For example, while in animals, plasma glucose
concentrations can be increased to within the diabetic range
(N300 mg/dl) following prolonged glucose infusion [6,7], in
humans, due to limitations in the rates and concentrations of the
infusates, plasma glucose levels are only marginally elevated,
typically within 100–120 mg/dl [8]. In non-diabetic, normal
weight subjects, plasma glucose levels are maintained within
this marginally elevated level by compensatory insulin release.
Therefore, the glucose infusion paradigm in humans is not
necessarily representative of a diabetic metabolic profile but
instead resembles that of obese, glucose intolerant individuals
with mild hyperglycemia and significant hyperinsulinemia.
To date, studies examining the effects of 48-h glucose
infusions have focused primarily on insulin responses to
standardized intravenous tests for assessing insulin secretion
and sensitivity using either the frequently sampled intravenous
glucose tolerance test [4,8] or a graded glucose infusion [3].
However, the consequences of prolonged glucose infusion on
subsequent hormonal responses to a physiologically-relevant
stimulus such as a mixed nutrient meal have not been evaluated.
Furthermore, little data are available regarding the effects of
consistently elevated glucose and insulin levels on other
hormones and metabolic fuels that may contribute to glucose
homeostasis and insulin sensitivity. In the present experiment,
we have evaluated the effect of a 48-h glucose infusion on
hormonal and metabolic responses during the infusion as well
as responses to a mixed nutrient meal at the end of the infusion
in healthy normal weight subjects. In addition, as previous
studies suggest that elevated levels of glucose reduce food
intake [9], we measured ad libitum food intake and hunger/
appetite ratings during the 48-h infusion period to determine if
normal, healthy individuals exhibit compensation for the large
increase in available calories during the glucose infusion. These
data provide interesting insights into the consequences of
prolonged mild elevations in plasma glucose and insulin such as
may occur during overfeeding conditions on food intake,
hunger and post-prandial responses to a test meal. The effects of
the prolonged 48-h glucose infusion on the plasma insulin and
glucose levels during the 48-h period have been previously
reported but all other data presented in this paper are new [10].
2. Methods
2.1. Subjects
Sixteen lean subjects (8 males and 8 females) 18–30 years of
age (mean 22.3±3.7 years) with body mass indexes (BMI)
ranging from 18.1 to 24 kg/m2 (mean 21.7±1.6 kg/m2) and a
percent body fat of 16.9±5.4% (range 7–18% for men and 16–
26% for women) as determined by bioelectrical impedance,
participated in this study. Subjects were recruited through
newspaper advertisements and each subject provided written
informed consent before entering the study. Two women
entered the study but then dropped out and their data are not
included in the data set. After a telephone interview to assess
eligibility, subjects underwent a physical examination, includ-ing an electrocardiogram and a medical history to ensure they
had no chronic illnesses including: diabetes, hypertension or
abnormal heart rhythms. Smokers, subjects taking prescription
medications and subjects with a family history of diabetes or
hypertension were also excluded from the study. A blood
sample was drawn after an overnight fast to evaluate clinical
blood chemistries and subjects were permitted to participate if
fasting plasma glucose was b110 mg/dl), hemoglobin levels
N12 mg/dl, and blood pressure was b140/90 mmHg. In order to
control for the effect of the menstrual cycle, all experimental
testing in women took place within the follicular phase of their
menstrual cycle. These studies were approved by the Institu-
tional Review Board of the University of Pennsylvania.
2.2. Experimental protocol
Each subject underwent two experimental conditions
administered in a counter-balanced order over a 2-month
period. Each experimental condition involved a 3-night stay in
the hospital and either a 48-h glucose infusion or a 48-h saline
infusion. Three hours after termination of the saline and glucose
infusions, the subjects ingested a standardized test meal.
On the evening before each experimental stay, the subjects
arrived at the General Clinical Research Center (GCRC) at the
Hospital of the University of Pennsylvania at 5:00 p.m. Subjects
were given dinner at 6:00 p.m. and a snack at 8:00 p.m., after
which they remained fasted until the following morning. During
their stay in the GCRC, the subjects were permitted to eat three
meals and a snack per day (ad libitum) but the meals were at
fixed time and they were only allowed to consume food items
prepared by the GCRC kitchen and selected from a pre-set
menu. Subjects were permitted to walk around the GCRC but
not allowed to leave the unit.
At 7:00 a.m., following an overnight fast, two intravenous
(i.v.) catheters were inserted in opposite arms, and an intra-
venous infusion of either saline (0.9% saline at a rate of 50 ml/h)
or glucose (15% dextrose solution at a rate of 200 mg/m2/min)
was initiated and sustained for a 48-h period. One i.v. line was
used for infusion and the other for blood sampling. Glucose
infusions were supplemented with 8 meq/l of KPh to prevent
hyperinsulinemia-induced hypokalemia. Blood was collected in
tubes containing EDTA, and the samples were kept on ice for not
longer than 1 h. Samples were then centrifuged and stored at
−80 °C for later assay.
2.3. Food intake, hunger ratings and taste measurements
To determine if the glucose infusion altered sweet taste
perception, a taste test was conducted after 24 h of glucose
infusion prior to breakfast. This time was selected as to not to
interfere with measurements of hunger ratings and of insulin
responses to meal ingestion conducted on the second day of the
glucose or saline infusions. Subjects were asked to taste 6
different concentrations of sucrose solutions (0.4%, 0.85, 1.6%,
4.0%, 8.0% and 16%) by keeping the solution briefly in their
mouth and then expectorating it. They were then asked to rate
them for sweet intensity and likeness, each on a nine point scale.
Table 1
Foods offered for ad libitum diet during 48-h infusion periods
Breakfast Lunch Dinner Snacks
Eggs Grilled cheese sandwich
(wheat or white)
Baked chicken Apple
Cream of
wheat
Macaroni and cheese Baked fish Orange
Oatmeal
(various
flavors)
Veggie burger Grilled cheese Bananas
Cereal (cold,
various
brands)
Turkey and/or
ham sandwich
Macaroni–
cheese
Grapes
Bacon Side salad with choice
of dressing
Veggie burger Ice cream
(various flavors)
Turkey bacon Steamed rice Hamburger Jello
Toast (white,
wheat)
Green beans Turkey/ham
sandwich
Pudding
(various flavors)
English
muffin
Mashed potatoes Side salad Pound cake
Bagel Carrots Steamed rice Milk (skim,
whole, 2%)
Apple Kaiser roll Green beans Juice (various)
Orange Bread (wheat or white) Mashed
potatoes
Spring water
Bananas Apple Carrots Decaffeinated
coffee/tea
Grapes Orange Kaiser roll Cream cheese
Milk (skim,
whole, 2%)
Bananas Bread
(wheat or white)
Butter
Juice
(various)
Grapes Ice cream
(various flavors)
Margarine
Spring water Ice cream (various
flavors)
Jello Ketchup
Decaffeinated
coffee/tea
Jello Pudding
(various flavors)
Jelly
Cream cheese Pudding (various
flavors)
Pound cake Salt
Butter Pound cake Milk (skim,
whole, 2%)
Pepper
Margarine Milk (skim, whole, 2%) Juice (various) Mustard
Ketchup Juice (various) Spring water Mayonnaise
Jelly Spring water Decaffeinated
coffee/tea
Salt Decaffeinated coffee/tea Cream cheese
Pepper Cream cheese Butter
Mustard Butter, margarine Margarine
Mayonnaise Ketchup Ketchup
Jelly Jelly
Salt, pepper Salt, pepper
Mustard Mustard
Mayonnaise Mayonnaise
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from a rotating menu with numerous meals offered. Many of
these meals are composed of mixed nutrients within a single
meal such as stew, lasagna, etc. and it is often difficult to
ascertain precise macronutrient intake from these meals, for
example, subjects may pick out certain items within a mixed
nutrient meal. Therefore, in order to be able to accurately
determine food intake during the 48-h infusion periods, a
specific menu was developed. The menu, illustrated in Table 1,
offered a large variety of single foods for breakfast, lunch,
dinner and snack. Subjects were told they could select as few or
as many foods as they wished and that they could request more
than one portion of each food. Unknown to the subjects, all
foods were weighed prior to presentation of the meals and then
following food intake. Macronutrient composition of the
individual foods was obtained either from the manufacturer or
from the Processor nutrient database made by ESHA, version
8.22. Hunger was determined using a visual analogue scale
ranging from 0–9 asking the following question “How hungry
do you feel right now?”
2.4. Meal challenge
Three hours after the termination of the glucose or saline
infusions and following a 15 min period of baseline sampling,
subjects were given a standardized mixed nutrient meal to
evaluate the effect of prolonged glucose infusion on hormonal
andmetabolic responses to a physiological stimulus. A 3-h delay
prior to the meal challenge was used to avoid the effects of
the glucose infusion on pancreatic β-cell “memory” and this
length of time has been previously identified as adequate [11].
Subjects were allotted 15 min to consume the meal. The
energy content of the meal was 600 kcal and was composed
of typical breakfast items including a grilled cheese sandwich,
corn flakes with milk and sugar and orange juice. The macro-
nutrient content was 15% protein, 60% carbohydrate and 25%
fat. This diet has been used in previous studies [12] and was
found to be acceptable to men and women in terms of both
palatability and quantity.
To obtain arterialized venous blood, an intravenous line was
inserted into a dorsal hand vein in a retrograde manner and the
hand heated in a thermoregulated box. The catheter was kept
patent by a slow infusion of saline. Subjects sat quietly for
30 min to acclimatize to the insertion of the catheters. Starting at
10:00, blood samples were taken at the following time points,
−15, −10, −5, 0, 2, 4, 6, 8, 10, 12, 14, 30, 45, 60, 75, 90, 105,
120, 135, 150, 165, 180, 195, 210, 225, 240 post-meal
ingestion. The meal was given at time=0. Each blood collection
involved a 4 ml sample collected into a Vacutainer containing
EDTA and a 3 ml sample collected into a Vacutainer containing
heparin for norepinephrine and epinephrine analysis. Samples
for catecholamine analysis were centrifuged and the plasma
mixed in a 96:4 ratio of plasma to 5N perchloric acid. The
samples were then re-centrifuged and the supernatant removed
and frozen at −80 °C. Samples for hormonal analysis were
centrifuged and the plasma was separated and stored in aliquots
at −80 C within 1 h of collection.2.5. Biochemical analysis
Plasma immunoreactive insulin, cortisol and pancreatic
polypeptide were measured in duplicate by double-antibody
radioimmunoassays. The antibodies were purchased from Linco
Research Inc., MO. The insulin antibody used is the human-
specific antibody from Linco with no crossreactivity (b0.2%) to
human proinsulin or the primary circulating split form. Analysis
of insulin and leptin were performed by the Diabetes Research
Center of the University of Pennsylvania. The inter-assay
coefficient of variation for insulin is 8% and the intra-assay
736 K.L. Teff et al. / Physiology & Behavior 90 (2007) 733–743variation is 6%. Plasma glucose was analyzed with a YSI
automated glucose/lactate monitor and free fatty acids and
triglycerides were determined by enzymatic assay using the
WAKO kit at the Monell Chemical Senses Center, Philadelphia
PA. Adiponectin was measured in the laboratory of Dr. Peter
Havel, UC Davis with a radioimmunoassay kit specific for
human adiponectin (HADP-61HK; Linco Research, St. Charles,
MO) after 1:500 dilution. Samples were analyzed in two
batches, with an intra-assay coefficient of variation (CV) 1.8–
6.2% and inter-assay CV 6.9–9.3% for duplicates over a range
of adiponectin concentrations.
2.6. Statistical analysis
To determine differences between variables during the
48-h infusion period, paired T-tests were conducted on
mean levels over the 48-h period. To determine significant
differences during the meal challenge, two approaches were
used: 1) multiple analysis of variance (MANOVA) was
conducted to determine if there were significant time and
treatment interactions over the 240 min post-prandial period
and 2) areas under the curve (AUC) were determined by
calculating AUCs over baseline. This was done by subtracting
the mean baseline value (first four blood samples) from the
amount of hormone or metabolite released at each time point.
Early (cephalic) phase insulin release was determined as
insulin released between 0 and 10 min after the beginning of
the meal ingestion. Post-prandial insulin AUCs were calcu-
lated from 10–240 min post-ingestion for a total of 230 min.
These data were then plotted and the area under the curve
calculated by a point-to-point method using computer
software (Origin, Northhampton, MA). Using the areas,
paired T-tests were performed to determine if there were
statistically significant differences between treatments. Sta-
tistical significance was Pb0.05.Fig. 1. A. (Left graph): plasma glucose levels (mean±standard error, n=16) during th
m2/min) was infused for a 48-h period. Arrows indicate time of meals (09:15, 13:15
14.1, Pb0.001. B. (Right graph): plasma insulin levels (mean±standard error, n=16)
(200 mg/m2/min) was infused for a 48-h period. Arrows indicate time of meals (09
F(18,198)=2.1, Pb0.01.3. Results
3.1. Plasma substrate and hormone concentrations during 48-h
infusions of glucose or saline
The infusion of glucose initially resulted in a transient
marked increase of plasma glucose concentrations to a mean
160 mg/dl. Thereafter, plasma glucose declined and was
increased by approximately 16% over the 48-h period compared
with saline infusion. Mean glucose levels over 48 h were 96.3±
6.8 mg/dl during the saline infusion compared with 112.6±
6.7 mg/dl during the glucose infusion (Pb0.0001; Fig. 1, left
hand graph). These relatively modest increases in plasma glu-
cose are in the range of those observed in subjects with impaired
fasting glucose and were achieved by the sustained increases in
plasma insulin. Plasma insulin levels were increased two-fold
during the glucose infusion to an average of 52.0±13.9 μU/ml
compared with during 25.8±7.3 μU/ml saline infusion
(Pb0.0001; Fig. 1, right hand graph). The insulin and glucose
data during the 48-h period have been reported in a previous
publication on heart rate variability [10] but all other data in this
paper have not been previously published.
A progressive increase of plasma leptin concentrations was
observed following the glucose infusion compared with saline
with a mean increase of 31% over the 48-h infusion period (5.9±
4.2 ng/ml, saline vs. 8.5±6.5 ng/ml, glucose, Pb0.002; Fig. 2,
left hand graph. Plasma adiponectin concentrations were not
different over the course of the glucose infusion compared with
the saline infusion (glucose; 6.6±1.9, saline; 6.6±2.2 μg/ml,
glucose) (Fig. 2, right hand graph). In contrast, the sustained
increases in plasma insulin resulted in a complete suppression of
free fatty acids during the 48-h glucose infusion period (0.12±
0.03 mM glucose) compared to the saline infusion (0.23±
0.06 mM, saline vs., Pb0.00003; Fig. 3, left hand graph).
Intravenous glucose infusion has been demonstrated to acutelye 2 experimental trials in which either saline (50 ml/h) or 15% dextrose (200 mg/
, 18:15 h) and evening snack (20:15 h). Treatment× time interaction: F(18,252)=
during the 2 experimental trials in which either saline (50 ml/h) or 15% dextrose
:15, 13:15, 18:15 h) and evening snack (20:15 h). Treatment× time interaction:
Fig. 2. A. (Left graph): plasma leptin levels (mean±standard error, n=16) during the 2 experimental trials in which either saline (50 ml/h) or 15% dextrose (200 mg/
m2/min) was infused for a 48-h period. Arrows indicate time of meals (09:15, 13:15, 18:15 h) and evening snack (20:15 h). Treatment× time interaction: F(18,216)=5.1,
Pb0.001. B. (Right graph): plasma adiponectin levels (mean±standard error, n=10) during the 2 experimental trials in which either saline (50 ml/h) or 15% dextrose
(200 mg/m2/min) was infused for a 48-h period. Arrows indicate time of meals (09:15, 13:15, 18:15 h) and evening snack (20:15 h). Treatment× time interaction:
F(18,99)=1.9, Pb0.05.
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[13]. In the present experiment, although PP does increase as
expected in response to meal ingestion under both study
conditions, mean plasma PP levels were significantly lower
over the course of the glucose compared with the saline infu-
sion (glucose; 196.4±103.1, saline, vs. 156.4±82.1 glucose,
Pb0.002, Fig. 3, right hand graph).
3.2. Effect of prior 48-h glucose and saline infusions on
circulating substrate and hormone responses to ingestion of a
standard meal
Three hours after the termination of the glucose infusion
plasma glucose concentrations had returned to baseline (83.8±
7.2 mg/dl, glucose vs. 81.8±7.4 mg/dl, saline). Plasma insulin
levels remained moderately elevated but within the normalFig. 3. A. (Left graph): plasma free fatty acids levels (mean±standard error, n=16) d
(200 mg/m2/min) was infused for a 48-h period. Arrows indicate time of meals (09
F(18,234)=9.2, Pb0.001. B. (Right graph): plasma pancreatic polypeptide levels (mea
(50 ml/h) or 15% dextrose (200 mg/m2/min) was infused for a 48-h period. Arrow
Treatment× time interaction: F(18,144)=2.5, Pb0.001.range following the glucose infusion (14.6±4.6 μU/ml, glucose
vs. 9.4±2.6 μU/ml, saline, Pb0.0001). HOMA-IR (homeostat-
ic model assessment-insulin resistance [14]) values calculated
from the fasting levels of glucose and insulin ((FPI (mU/ml)
⁎FPG (mmol/l)) / 22.5) indicated a significant increase in
insulin resistance as HOMA-IR values increased from 1.9+
0.6 3 h after termination of the saline infusion to 3.0+0.9 3 h
after the glucose infusion (Pb0.0001).
During the meal challenge, plasma glucose excursions
(Fig. 4, left hand graph) were significantly decreased following
the glucose infusion compared to the saline infusion (treat-
ment × time interaction, F(25,50)=3.8, Pb0.001). No treatment
or treatment by time effects were found for plasma insulin
(Fig. 4, right hand graph). However, when the areas under the
curve (AUCs) for the 4 h after the meal were calculated,
significant differences in glucose and insulin were found. Theuring the 2 experimental trials in which either saline (50 ml/h) or 15% dextrose
:15, 13:15, 18:15 h) and evening snack (20:15 h). Treatment× time interaction:
n±standard error, n=16) during the 2 experimental trials in which either saline
s indicate time of meals (09:15, 13:15, 18:15 h) and evening snack (20:15 h).
Fig. 4. A. (Left graph): plasma glucose levels (mean±standard error, n=16) following the ingestion of a standardized mixed nutrient meal, 3 h after the termination of
the infusion in which either saline (50 ml/h) or 15% dextrose (200 mg/m2/min) was infused for a 48-h period. Treatment× time interaction: F(25,150)=3.8, Pb0.001.
B. (Right graph): plasma insulin levels (mean±standard error, n=16) following the ingestion of a standardized mixed nutrient meal, 3 h after the termination of the
infusion in which either saline (50 ml/h) or 15% dextrose (200 mg/m2/min) was infused for a 48-h period. Treatment× time interaction: F(25,125)=1.2, P=0.22 inset:
early phase insulin response (0–10 min post-ingestion) difference from mean baseline values (mean±standard error, n=16) following the ingestion of a standardized
mixed nutrient meal, 3 h after the termination of the infusion in which either saline (50 ml/h) or 15% dextrose (200 mg/m2/min) was infused for a 48-h period.
Treatment effect F(1,11)=Pb0.001, post-hoc analysis, ⁎Pb0.05.
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decreased following the 48-h glucose infusion compared to
the saline condition (1922±1432 mg/dl/230 min, glucose vs.
4776±2141 mg/dl/230 min saline, Pb0.0001) as were the
insulin AUCs (5539±2204 μU/ml/230 min, glucose vs. 8084±
4305 μU/ml/230 min, saline, Pb0.004) (Table 2). In addition,
the AUCs were determined for the pre-absorptive early phase
period (0–10 min). Early phase insulin (inset Fig. 4) was
increased following the glucose infusion (52.4±45.9 μU/ml/
10 min) compared to saline (34.2±26.8 μU/ml/10 min, Pb0.05)
despite no significant differences in early phase AUC for glucose
between the two conditions (Table 2).
Plasma triglycerides were measured in a subset of subjects
(n=7) during the meal challenge (Table 3). Significant
elevations in post-prandial triglyceride levels were observedTable 2
Area under the curve (AUC; mean±standard deviation, n=16) for the early
phase (0–10 min) and post-prandial phase (10–240 min) during the meal
challenge test following the 48-h glucose or saline infusion
48-h Saline infusion 48-h Glucose infusion
Early phase
(0–10 min)
Post-prandial
(10–240 min)
Early phase
(0–10 min)
Post-prandial
(10–240 min)
AUC glucose
(mg/dl/time)
25.3±25.5 4776±2141 14.1±22.9 2085±1342 ⁎
AUC insulin
(μU/ml/time)
34.2±26.8 8084±4305 52.4±
45.9 ⁎
5539±2204 ⁎
AUC pancreatic
polypeptide
(pg/ml/time)
2119±1110 42,878±
23,088
1763±
1189
46,045±
32,016
AUC triglycerides
(mg/dl)
29.9+10.2 1100.9+
557.8
25.2+11.9 6553.9+
1212.3 ⁎
⁎ Pb0.05, significantly different from 48-h saline infusion condition.following the glucose infusion compared to the saline (6554±
3207 mg/dl/230 min glucose vs. 1101±1476 mg/dl/230 min
saline, Pb0.02). Interestingly, plasma free fatty acid concentra-
tions remained suppressed 3 h after termination of the glucose
infusion (data not shown). No significant differences between
glucose and saline treatments in the calculated AUCs for
pancreatic polypeptide (Table 2), norepinephrine or epinephrine
(data not shown) were observed.
3.3. Ad libitum food intake, hunger ratings and sweet taste
perceptions during 48-h infusions of glucose or saline
The mean number of kilocalories supplied by the glucose
infused over each 24-h period was 2021±216 kcal. The large
number of calories infused as glucose (N4000 over 48 h) had no
effect on the subject's self-reported hunger over the 48-h period
(Fig. 5 left hand graph) although a trend towards a decrease was
evident by the end of the 48-h glucose infusion. No significant
differences were found between the mean caloric intake duringTable 3
Intensity and hedonic ratings of varying concentrations of sucrose solutions
following the 24-h saline and glucose infusions (mean±standard error)
Percent
sucrose
solution
Intensity rating Hedonic rating
Saline infusion Glucose infusion Saline infusion Glucose solution
0.4 1.5±0.2 1.8±0.3 3.4±0.5 3.9±0.6
0.8 1.9±0.2 2.1±0.2 3.4±0.6 3.5±0.6
1.6 3.0±0.4 2.9±0.3 3.0±0.5 4.0±0.5
4.0 4.5±0.4 5.1±0.4 3.9±0.5 4.1±0.4
8.0 6.7±0.3 6.9±0.4 4.9±0.5 5.1±0.5
16 7.4±0.4 7.3±0.4 4.9±0.6 5.0±0.6
Fig. 5. A. (Left graph): hunger ratings (mean±standard error, n=16) during the 2 experimental trials in which either saline (50 ml/h) or 15% dextrose (200 mg/m2/min)
was infused for a 48-h period. Before each meal (09:00, 13:00, and 18:00 h) and at 22:00 h, subjects were asked to rate their hunger on a scale from 1 to 9 where 1 was
“not hungry at all” and 10 was “extremely hungry”. B. (Right graph): total macronutrient content of the food ingested during the 2 experimental trials in which either
saline (50 ml/h) or 15% dextrose (200 mg/m2/min) was infused for a 48-h period.
739K.L. Teff et al. / Physiology & Behavior 90 (2007) 733–743the 48-h glucose infusion compared to the saline infusion
periods (5773±484 kcal/48 h, saline vs. 5840±491 kcal/48 h,
glucose) (Fig. 5 right hand graph). Similarly, no significant
differences were found between the individual macronutrients
selected on the days of glucose infusion compared to saline
infusion: protein (206±19 g/48 h, saline vs. 207±15 g/48 h,
glucose), carbohydrate (784±56 g/48 h, saline vs. 789±55 g/
48 h, glucose), fat (214±27 g/48 h, saline vs. 218±26 g/48 h,
glucose). Food intake during each of the 2 days and during
individual meals was also analyzed and no significant
differences were found (data not shown). Thus, despite the
large number of calories being infused and the sustained
elevations in plasma glucose, insulin, and leptin concentrations,
subjects did not decrease their caloric intake during glucose
infusion.
Twenty-four hours of glucose infusion had no effect on sweet
taste perception or on the hedonic likeness rating of sweet
solutions (Table 3).Fig. 6. A. (Left graph): relationship between mean of 16 hunger ratings taken over the
over the same 48-h time period. R=0.52, P=0.51. B. (Right graph): relationship betw
kilocalories ingested over the same 48-h time period. R=0.68, Pb0.007⁎. ⁎ = Pb03.4. Correlations between hormonal and behavioral measures
We examined the relationship between the hormonal
responses during the 48-h infusions and the behavioral
responses of food intake and hunger. Fig. 6 illustrates the
relationship between hunger and cumulative food intake over
the 48-h infusion periods. In the present study, a positive
correlation between hunger and food intake was observed
during the saline infusion (Fig. 6, left graph) but this
relationship just barely reached statistical significance
(P=0.05). In contrast, during the glucose infusion, the
variability decreased and the correlation became highly
significant (Pb0.007; Fig. 6, right graph). Although one
would assume that hunger ratings should correlate with food
intake, this relationship is often not observed in human studies.
Similarly, the relationship between food intake and plasma
leptin levels was enhanced during the glucose infusion. No
significant relationship between leptin and food intake was48-h period of saline infusion and the amount of ad libitum kilocalories ingested
een mean of 16 hunger ratings taken over the 48-h period of glucose infusion and
.05.
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during the glucose infusion which increased plasma leptin
levels, food intake decreased with increasing leptin (R=−0.79,
Pb0.003) (Fig. 7, upper right graph). Thus, despite no signifi-
cant differences in overall food intake between the two expe-
rimental conditions, induced increases in plasma leptin levels by
the glucose infusion, tightened the relationship between food
intake and leptin levels. A significant inverse correlation was
observed between leptin and hunger, independent of treatment
(Fig. 7, bottom left and right graphs). If the data from the two
treatments are combined, the overall inverse correlation between
hunger and leptin levels was found to be R=−0.48, Pb0.01. To
our knowledge, this is a first demonstration of a relationship
between leptin and hunger ratings as well as leptin and food
intake, in a non-calorically restricted non-obese population.
Surprisingly, no statistically significant correlations were
found between insulin and food intake (R=0.38, P=0.15, saline
infusion; R=0.21, P=0.44, glucose infusion) or glucose and
food intake (R=0.31, P=0.25, saline; R=0.22, P=0.41, glucose
infusion). However, the quantity of food ingested during the 48-
h period was inversely correlated with the post-prandial insulin
response to the meal, i.e. the greater the kilocalorie intake over
the 48-h period, the lower the post-prandial insulin response.Fig. 7. A (Left, upper graph): relationship between mean of 16 hunger ratings taken o
taken over the same 48-h period. R=−0.65, P=0.02⁎. B (Right, upper graph): relatio
infusion and the mean of 38 plasma leptin samples taken over the same 48-h period
ingested over the 48-h period of saline infusion and the mean of 38 plasma leptin s
graph): relationship between kilocalories ingested over the 48-h period of glucose infu
R=−0.79, Pb0.003⁎. ⁎ = Pb0.05.This relationship held true independent of whether saline (R=
−0.60, Pb0.04) or glucose (R=−0.59, Pb0.02) was infused.
Food intake over the 48-h period was also inversely correlated
with post-prandial glucose levels during the saline infusion (R=
−0.68, Pb0.01) but during the glucose infusion, this relation-
ship was disrupted (R=−0.12, P=0.55). If individual macro-
nutrient intakes over the 48-h period were correlated with post-
prandial insulin levels, both carbohydrate intake in grams (R=
−0.62, Pb0.01) and fat intake in grams (R=−0.65, Pb0.01)
were statistically significant during the saline infusion but only
fat intake remained significantly correlated during the glucose
infusion (R=−0.50, Pb0.02).
4. Discussion
In the present study, we investigated the effects of prolonged
mild hyperglycemia induced by a 48-h glucose infusion on
hormonal responses, food intake and hunger during the infusion
period and subsequently on post-prandial responses to a standard
test meal. Prolonged glucose infusion produced modest eleva-
tions of plasma glucose in the range of 110mg/dl, coupled with a
two-fold increase of plasma insulin concentrations compared
with saline infusion. Circulating levels of leptin were alsover the 48-h period of saline infusion and the mean of 38 plasma leptin samples
nship between mean of 16 hunger ratings taken over the 48-h period of glucose
. R=−0.62, P=0.03⁎. C. (Left, lower graph): relationship between kilocalories
amples taken over the same 48-h period. R=−0.33, P=0.26. D. (Right, lower
sion and the mean of 38 plasma leptin samples taken over the same 48-h period.
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observed after more short term infusions of exogenous insulin
and glucose [15,16]. This metabolic profile of hyperinsulinemia,
hyperleptinemia coupled with mildly elevated plasma glucose
levels is similar to that of obese, glucose intolerant individuals
with moderate insulin resistance. However, insulin resistance is
typically associated with elevations in free fatty acids (FFAs)
which in this experimental manipulation were completely
suppressed by the glucose-induced hyperinsulinemia. Further-
more, plasma adiponectin concentrations, which are usually
decreased in obese insulin resistant subjects [17–19], were not
significantly different during the insulin and saline infusions,
most likely due to the low body fat of the participating subjects
[19]. Thus, this experimental paradigm uncouples the glucose
homeostatic parameters, glucose and insulin and to some degree,
leptin, the production of which is dependent on insulin mediated
glucose metabolism, from those variables often associated
specifically with increased body adiposity such as elevated FFA
and decreased adiponectin.
Three hours after the glucose infusion, despite insulin and
glucose levels within the normal range, the HOMA-IR, a
parameter of insulin sensitivity suggested an induction of insulin
resistance by the glucose infusion. However, if the 48-h glucose
infusion induced insulin resistance, one would predict a larger
post-prandial increase of insulin in response to the test meal.
Instead, we observed a substantial decrease of post-prandial
glucose excursions and a modest reduction of post-prandial
insulin secretion in response to meal ingestion after the glucose
infusion compared with the saline infusion. The discrepancy
between the predicted response based on the HOMA which is
derived from static insulin and glucose values and the actual
dynamic insulin responses to a physiologically-relevant chal-
lenge reveals the limitation of HOMA as an assessment of
insulin resistance. We postulate that the attenuation in post-
prandial glucose levels may be a consequence of an increase in
early phase insulin release (Fig. 4, inset) which has been shown
to play an important role in glucose tolerance [20–23]. In fact,
our laboratory has demonstrated that the presence of early phase
insulin secretion can lower post-prandial glucose levels by 30%
in normal weight and obese subjects. The increase in early phase
insulin release may be a consequence of an induction of vagal
efferent activity at the level of the pancreas or due to a recruit-
ment of insulin vesicles to the perimeter of the B-cell [24] as a
consequence of the prolonged glucose infusion, thereby facili-
tating rapid early phase insulin secretion in response to the meal
challenge.
The increase of plasma triglyceride levels beginning ∼2 h
after the test meal was the only metabolic parameter associated
with lipid metabolism that was altered by the prolonged glucose
infusion (Table 2). The increase in post-prandial triglycerides
may have been due to an increase in triglyceride synthesis as a
consequence of induction of lipogenic enzymes such as fatty
acid synthase that are known to be induced in response to insulin
and glucose [25]. As elevated post-prandial triglycerides are
associated with insulin resistance and atherosclerosis [26,27],
the change in triglyceride response may be an early metabolic
alteration to hypercaloric conditions and that precedes thedevelopment of insulin resistance. Furthermore, triglycerides
inhibit leptin transport across the blood-brain barrier, thereby
contributing to the development of insulin resistance [28].
During the infusion periods, hunger and food intake were
positively correlated, a relationship which became more tightly
coupled and more significant during the glucose infusion
condition (Fig. 6). However, despite the large number of
calories infused (∼4000 kcal) over the 48-h period, we found
no significant decreases in hunger ratings or the quantity of food
or macronutrients content the subjects consumed ad libitum
(Fig. 5). Elevations in glucose are thought to reduce food intake
[29] while declines in blood glucose are postulated to stimulate
food intake [30]. Glucose infused at 25% of basal caloric intake
significantly reduced food intake in baboons [31] by 2–3 days
although the infusion took place for a substantially longer time
period (12–21 days). In humans, the effect of acute glucose
infusions (2–5 h) are equivocal with some studies reporting an
increase in hunger and food intake [32] while others report no
effect [33] Healthy subjects undergoing chronic glucose
infusion (5–6 days) reduced their food intake to adequately
compensate for the percentage of infused nutrients [9] although
in this study, subjects were restricted to only ingesting a
commercial liquid diet, thereby limiting sensory stimulation. In
contrast, the subjects in the present study were provided with a
large array of foods from which they could select their meals
and under these conditions, subjects ate very similar quantities
and composition of food irrespective of the infusate.
Energy regulation theories predict that subjects would
compensate for the infused calories by decreasing their food
intake. Both insulin [34] and leptin [18,35] are known to
function as signals to the central nervous system in the long-
term regulation of food intake and energy homeostasis. We
found significant negative correlations between the mean of the
plasma leptin levels over the 48-h period and the mean of the
hunger ratings over the same period (Fig. 7, upper graphs), that
is, as leptin increased, hunger ratings declined. To our knowl-
edge, a significant correlation between increasing leptin and
decreasing hunger has not been previously reported in a non-
energy restricted population. The two studies reporting
significant relationships between leptin and hunger [36] or
leptin and satiety [37] were both in normal weight or obese
women, respectively on calorically restricted diets resulting in
weight loss. Other studies reporting a lack of the relationship
between leptin and hunger were typically conducted in acute,
meal to meal studies [38,39]. Furthermore, in our normal weight
subjects, the increase in leptin induced by the glucose infusion,
resulted in a very strong negative correlation between leptin and
food intake (Fig. 7, B) that was not evident during the saline
infusion conditions (Fig. 7A). Thus, this normal weight pop-
ulation which would not be expected to exhibit central leptin
resistance was responsive to the increase in leptin although this
was not manifested during the 48-h period of testing. We would
speculate that if the glucose infusion was continued, a reduction
in food intake may have been evident. It should be noted that
this is a small group of subjects and perhaps, a larger group
would have provided the statistical power to overcome the large
variation in food intake notable in human populations.
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extremely limited as accurate intake can only be assessed in a
laboratory situation. Conversely, eating behavior is most likely
not “normal” in a laboratory setting. No significant correlation
was found between mean 48-h insulin values and food intake
although surprisingly, the quantity of total kilocalories ingested
was inversely correlated to the post-prandial insulin response.
In conclusion, we found that a 48-h glucose infusion elicits a
metabolic profile of mild hyperglycemia, hyperinsulinemia and
hyperleptinemia. Post-prandial glucose excursions and insulin
secretion were attenuated in response to ingestion of a standard
meal following the glucose infusion compared with the saline
infusion. The reduction in post-prandial glucose may be a
consequence of an increase in early phase insulin release as
suggested by some previous studies, although additional
experiments are needed to determine if this is the mediating
mechanism. We also found that when given the opportunity to
freely select and ingest food ad libitum the human subjects do
not compensate for infused calories provided by glucose over a
48-h period and do not reduce their food intake despite
sustained elevations glucose, insulin, and leptin within the
physiological range. However, significant inverse correlations
between food intake and plasma leptin levels as well as hunger
and leptin were found for the first time in a normal weight,
freely eating group of subjects. These data highlight the
importance of investigating behavioral responses to physiolog-
ical stimuli in as close to “real-world” conditions as possible and
to recognize that adaptations to over-nutrition are likely to
require prolonged periods of time to manifest and may be
blunted, particularly in individuals prone to weight gain such as
obese, glucose intolerant, insulin resistant subjects.
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